Agilent's Q1 Revenues Rise but Profits Drop 20 Percent | GenomeWeb
This article has been updated to include comments from a conference call.
 
NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Wednesday that its first-quarter revenues rose 9 percent, with strong growth coming from its Bio-Analytical Measurement segment. But its profits dropped 20 percent due to share-based compensation expense.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.